X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2983) 2983
Book Review (448) 448
Publication (445) 445
Book Chapter (7) 7
Conference Proceeding (4) 4
Dissertation (3) 3
Book / eBook (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2755) 2755
humans (2026) 2026
animals (1468) 1468
hydroxamic acids - pharmacology (1279) 1279
oncology (897) 897
male (887) 887
female (823) 823
histone deacetylase inhibitors (815) 815
mice (805) 805
suberoylanilide hydroxamic acid (798) 798
hydroxamic acids - administration & dosage (743) 743
histone deacetylase inhibitors - pharmacology (717) 717
cancer (679) 679
apoptosis (596) 596
cell line, tumor (568) 568
histone deacetylase inhibitor (521) 521
hydroxamic acids - therapeutic use (516) 516
pharmacology & pharmacy (502) 502
acetylation (441) 441
expression (434) 434
apoptosis - drug effects (428) 428
histone deacetylase (421) 421
vorinostat (389) 389
rats (367) 367
antineoplastic agents - pharmacology (351) 351
gene expression (348) 348
middle aged (345) 345
analysis (344) 344
research (344) 344
histone deacetylases - metabolism (339) 339
cell proliferation - drug effects (315) 315
article (313) 313
histone deacetylase inhibitors - therapeutic use (312) 312
cell biology (303) 303
biochemistry & molecular biology (300) 300
aged (299) 299
care and treatment (299) 299
dose-response relationship, drug (290) 290
adult (289) 289
histones - metabolism (288) 288
histone deacetylase inhibitors - administration & dosage (287) 287
antineoplastic agents - therapeutic use (283) 283
drug synergism (274) 274
hematology (274) 274
proteins (269) 269
enzyme inhibitors - pharmacology (261) 261
epigenetics (243) 243
antineoplastic combined chemotherapy protocols - therapeutic use (242) 242
hydroxamic acids - adverse effects (238) 238
gene-expression (236) 236
health aspects (233) 233
chemotherapy (229) 229
disease models, animal (217) 217
in-vitro (216) 216
neoplasms - drug therapy (216) 216
valproic acid (213) 213
drug therapy (211) 211
treatment outcome (207) 207
hdac inhibitors (205) 205
hydroxamic acid (205) 205
cells (202) 202
saha (202) 202
tumors (197) 197
therapy (192) 192
chromatin (190) 190
in-vivo (188) 188
dna methylation (184) 184
research article (177) 177
administration, oral (173) 173
hydroxamic acids - chemistry (173) 173
cells, cultured (172) 172
hydroxamic acids - pharmacokinetics (171) 171
medicine & public health (171) 171
genetic aspects (170) 170
chemistry, medicinal (169) 169
histones (169) 169
mice, inbred c57bl (169) 169
antineoplastic agents - administration & dosage (166) 166
growth (164) 164
trichostatin a (164) 164
xenograft model antitumor assays (163) 163
antineoplastic combined chemotherapy protocols - pharmacology (162) 162
activation (161) 161
cell survival - drug effects (161) 161
neurosciences (154) 154
inhibitors (153) 153
hydroxamic acids (151) 151
bortezomib (150) 150
phase-i (149) 149
physiological aspects (149) 149
hdac inhibitor (147) 147
gene expression regulation, neoplastic - drug effects (146) 146
medicine (145) 145
t-cell lymphoma (144) 144
antineoplastic agents (143) 143
cancer therapies (142) 142
cell cycle (141) 141
time factors (140) 140
acetylation - drug effects (139) 139
clinical trials (139) 139
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2939) 2939
Japanese (14) 14
French (10) 10
German (10) 10
Italian (4) 4
Russian (4) 4
Chinese (3) 3
Dutch (2) 2
Lithuanian (1) 1
Polish (1) 1
Portuguese (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 07/2012, Volume 487, Issue 7408, pp. 482 - 485
Despite antiretroviral therapy, proviral latency of human immunodeficiency virus type 1 (HIV-1) remains a principal obstacle to curing the infection(1).... 
CELLS | ACTIVATION | SUBEROYLANILIDE HYDROXAMIC ACID | MULTIDISCIPLINARY SCIENCES | IN-VIVO | VALPROIC ACID | INFECTION | HISTONE DEACETYLASE INHIBITORS | TYPE-1 | EXPRESSION | PCR | Gene Expression Regulation, Viral - drug effects | Humans | Hydroxamic Acids - adverse effects | Histone Deacetylase Inhibitors - administration & dosage | RNA, Viral - blood | Virus Latency - drug effects | Proviruses - drug effects | HIV-1 - growth & development | Proviruses - genetics | Hydroxamic Acids - administration & dosage | Anti-HIV Agents - therapeutic use | CD4-Positive T-Lymphocytes - virology | Hydroxamic Acids - pharmacology | Biomarkers - metabolism | HIV Infections - blood | Risk Assessment | HIV-1 - drug effects | CD4-Positive T-Lymphocytes - cytology | HIV Infections - virology | RNA, Viral - biosynthesis | CD4-Positive T-Lymphocytes - metabolism | Viremia - drug therapy | HIV-1 - genetics | Proviruses - growth & development | Histones - drug effects | Up-Regulation - drug effects | Acetylation - drug effects | Viremia - virology | HIV Infections - drug therapy | Histone Deacetylase Inhibitors - pharmacology | Histones - metabolism | CD4-Positive T-Lymphocytes - drug effects | Histone Deacetylase Inhibitors - adverse effects | Physiological aspects | Antiviral agents | HIV patients | Health aspects | Vorinostat | Antiretroviral drugs | Plasma | Cell culture | Lymphocytes | Human immunodeficiency virus--HIV | Genomes | Drug therapy | Drug dosages | Index Medicus
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1195 - 1206
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2015, Volume 33, Issue 23, pp. 2492 - 2499
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2009, Volume 15, Issue 16, pp. 5250 - 5257
Journal Article
Blood, ISSN 0006-4971, 01/2007, Volume 109, Issue 1, pp. 31 - 39
Journal Article
Nature Medicine, ISSN 1078-8956, 06/2015, Volume 21, Issue 6, pp. 555 - 559
Journal Article
Leukemia, ISSN 0887-6924, 08/2013, Volume 27, Issue 8, pp. 1628 - 1636
Journal Article